行业ETF风向标丨创新药关注度升温，港股通创新药ETF半日涨幅近2%

每日经济新闻12-03

炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！　　每经记者刘明涛每经编辑彭水萍　　今日上午，创新药板块整体较为强势，其中，港股通创新药ETF（159570）半日涨幅接近2%，是今日行业ETF中表现最为突出的品种。　　从投资逻辑来看，进入“十四五”，创新药产业运行至研发升级、创新求真、国际融合的高质量发展阶段，产业迎来转型升级历史机遇。从二季度业绩来看...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2488959439?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-12-03 13:19","share_image_url":"https://static.laohu8.com/b0d1b7e8843deea78cc308b15114de44","id":"2488959439","market":"sh","top_or_hot":-1,"title":"行业ETF风向标丨创新药关注度升温，港股通创新药ETF半日涨幅近2%","media":"每日经济新闻","content":"<div>\n<p>炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ 　　每经记者 刘明涛    每经编辑 彭水萍\n　　今日上午，创新药板块整体较为强势，其中，港股通创新药ETF（159570）半日涨幅接近2%，是今日行业ETF中表现最为突出的品种。\n\n　　从投资逻辑来看，进入“十四五”，创新药产业运行至研发升级、创新求真、国际融合的高质量发展阶段，产业迎来转型升级历史机遇。从二季度业绩来看...</p>\n\n<a href=\"https://finance.sina.com.cn/roll/2024-12-03/doc-incyeerv4955920.shtml\">网页链接</a>\n\n</div>\n","source":"sina","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>行业ETF风向标丨创新药关注度升温，港股通创新药ETF半日涨幅近2%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n行业ETF风向标丨创新药关注度升温，港股通创新药ETF半日涨幅近2%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-12-03 13:19 北京时间&nbsp;&nbsp;&nbsp;<a href=https://finance.sina.com.cn/roll/2024-12-03/doc-incyeerv4955920.shtml><strong>每日经济新闻</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ 　　每经记者 刘明涛    每经编辑 彭水萍\n　　今日上午，创新药板块整体较为强势，其中，港股通创新药ETF（159570）半日涨幅接近2%，是今日行业ETF中表现最为突出的品种。\n\n　　从投资逻辑来看，进入“十四五”，创新药产业运行至研发升级、创新求真、国际融合的高质量发展阶段，产业迎来转型升级历史机遇。从二季度业绩来看...</p>\n\n<a href=\"https://finance.sina.com.cn/roll/2024-12-03/doc-incyeerv4955920.shtml\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"159992","symbol_name":"创新药","start_time":0,"source_url":"https://finance.sina.com.cn/roll/2024-12-03/doc-incyeerv4955920.shtml","article_id":"2488959439","we_media_id":null,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2024-12-03/doc-incyeerv4955920.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2488959439","pubTimestamp":1733203140,"columns":[],"sourceInfo":{"source_id":"sina","name":"sina"},"weMediaInfo":null,"summary":"　　今日上午，创新药板块整体较为强势，其中，港股通创新药ETF半日涨幅接近2%，是今日行业ETF中表现最为突出的品种。　　点评：港股通创新药ETF和港股创新药ETF今日上午分别上涨1.81%和1.61%，其中，港股通创新药ETF规模较大，达到5.92亿份，其半日成交金额为3766万元，上述两只ETF均追踪的是国证港股通创新药指数。","collect":0,"end_time":0,"defaultTopTitle":"sina.com.cn","property":[],"viewcount":null,"language":"zh","relate_stocks":{"159992":"创新药","515120":"创新药ETF","YANG":"三倍做空富时中国ETF-Direxion","06978":"永泰生物-B","BK4585":"ETF&股票定投概念","BK1161":"生物科技","BK1574":"生物医药B类股","HSCEI":"国企指数","BK4550":"红杉资本持仓","BK4588":"碎股","FDN":"First Trust Dow Jones Internet I","HSTECH":"恒生科技指数"},"translate_title":"Industry ETF Wind Vane | Attention to innovative drugs is heating up, and the Hong Kong Stock Connect Innovative Drug ETF rose nearly 2% in half a day","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"159992":0.6,"515120":0.6,"06978":0.6,"FDN":0.6,"HSCEI":0.6,"HSTECH":0.6,"YANG":0.6},"content_text":"炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ 　　每经记者 刘明涛    每经编辑 彭水萍\n　　今日上午，创新药板块整体较为强势，其中，港股通创新药ETF（159570）半日涨幅接近2%，是今日行业ETF中表现最为突出的品种。\n\n　　从投资逻辑来看，进入“十四五”，创新药产业运行至研发升级、创新求真、国际融合的高质量发展阶段，产业迎来转型升级历史机遇。从二季度业绩来看创新药中biotech优质个股逐步走向盈利周期，传统Pharma公司创新管线步入兑现期，存量业务逐步出清，整体板块业绩改善趋势明显，同时叠加宏观利好政策推出，业绩改善有望延续，板块具备较高配置价值。\n　　点评：港股通创新药ETF（159570）和港股创新药ETF（159567）今日上午分别上涨1.81%和1.61%，其中，港股通创新药ETF（159570）规模较大，达到5.92亿份，其半日成交金额为3766万元，上述两只ETF均追踪的是国证港股通创新药指数。\n　　国证港股通创新药指数在香港市场中选取具备互联互通标的资格、公司业务涉及创新药研发、生产等领域的生物医药公司作为指数样本，反映港股通创新药产业上市公司的运行特征。该指数具有以下特点；首先，指数全面覆盖创新药产业，其他生物制品和化学制剂权重占比高；其次，市值分布偏中小盘，估值处于历史低位，投资性价比较高。\n国证港股通创新药指数主要权重股 \n　　点评：港股创新药ETF基金（520700）和港股创新药50ETF（513780）半日涨幅分别为1.63%和1.44%，两只ETF规模目前都较小，追踪的是中证港股通创新药指数。\n　　中证港股通创新药指数从港股通范围内选取50只业务涉及创新药研发以及为制药企业提供药物研究、开发和生产等服务的上市公司证券作为指数样本，以反映港股通范围内创新药上市公司证券的整体表现。\n中证港股通创新药指数主要权重股\n\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：何松琳","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2488959439"}